Investment bank Leerink Partners announces the initiation of research coverage on biopharmaceutical company Kailera Therapeutics.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
The institution has given the company a “outperform” initial rating and set a target price of $36 per share.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Overview of Key Overnight Developments on May 13
金色财经•2026/05/12 23:41
Futures Hotspot Tracking
金十•2026/05/12 23:34
Wallstreetcn Morning Briefing | May 13, 2026
华尔街见闻•2026/05/12 23:15
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$80,570.16
-1.38%
Ethereum
ETH
$2,281.96
-2.30%
Tether USDt
USDT
$0.9997
+0.00%
BNB
BNB
$665.36
-0.49%
XRP
XRP
$1.44
-2.30%
USDC
USDC
$0.9998
-0.01%
Solana
SOL
$94.65
-2.58%
TRON
TRX
$0.3495
-0.51%
Dogecoin
DOGE
$0.1102
-0.75%
Hyperliquid
HYPE
$40.47
-3.53%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now